Strategy for improving clinical obesity therapeutics
改善临床肥胖治疗的策略
基本信息
- 批准号:MR/Y014707/1
- 负责人:
- 金额:$ 84.24万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Research Grant
- 财政年份:2024
- 资助国家:英国
- 起止时间:2024 至 无数据
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Obesity is a global health problem affecting millions of people. It contributes to various health problems like heart disease, diabetes, and even certain types of cancer. Intuitively, this has huge societal and economic implications costing about £6 billion annually to the NHS alone, a figure projected to rise to about £10 billion each year by 2050. While healthy diet and exercise are the first line of intervention and should be promoted, they are often insufficient, and medical interventions become necessary for a significant number of people. One of the most effective treatments so far has been weight-loss surgery, but it is invasive, costly, and not practical when considering the epidemic proportion of the obesity problem. Therefore, finding an affordable, less invasive, and more universally applicable solutions is crucial.In this context, our team is set to explore a promising new drug, called Tirzepatide. This medication, originally developed for type 2 diabetes, has shown extraordinary results in helping people lose weight. In fact, its effects are almost comparable to those of weight-loss surgery, and superior to any other drug so far tested clinically. However, the exact way by which Tirzepatide achieves these remarkable results are currently unknown.That is where our research comes in. We aim to delve into the mechanisms through which Tirzepatide achieve its remarkable clinical outcomes, focusing particularly on its effects on the brain, as we believe that this is where the drug acts to exert its major impact on body weight. We will be using a 'reverse translational' approach, which means we start with what we already know from patient experiences and clinical trials, then work backward using laboratory mouse models to uncover the underlying biological processes. We will be using advanced genetic tools, which can be thought of as advanced biological controls, to find the specific brain cells that the drug interacts with to help people lose weight. These tools give us the power to flip these cells on or off whenever we want, just like switching a light on or off using a remote control. This will help us understand what exactly these cells are doing where the drug is working. In simpler terms, we are trying to find and study the 'weight loss' cells in the brain that this drug talks to.The goal of this research is to gain a thorough understanding of how Tirzepatide interacts with the body's systems to cause weight loss. We believe that this knowledge will be critical not only for a better-informed use of Tirzepatide itself, but also guiding the development of new treatments. Additionally, by pinpointing the specific 'weight loss' brain cells that this drug interacts with, we are also likely to gain a deeper understanding of the fundamental processes controlling body weight and how these processes go awry in obesity. This knowledge could offer hope for the development of more personalised and effective treatments in the future. As such, our research holds the potential to provide a more comprehensive understanding of obesity, and, importantly, to inform the development of more efficient, scalable, and affordable solutions to combat this widespread health challenge.
肥胖是一个影响数百万人的全球性健康问题。它会导致各种健康问题,如心脏病、糖尿病,甚至某些类型的癌症。直观地说,这对社会和经济产生了巨大的影响,仅NHS每年就要花费60亿英镑,预计到2050年,这一数字将上升到每年100亿英镑左右。虽然健康饮食和运动是干预的第一线,应该加以促进,但它们往往是不够的,对相当多的人来说,医疗干预是必要的。到目前为止,最有效的治疗方法之一是减肥手术,但考虑到肥胖问题的流行比例,它是侵入性的,昂贵的,而且不实用。因此,找到一种负担得起、侵入性更小、更普遍适用的解决方案至关重要。在这种情况下,我们的团队将探索一种有前途的新药,叫做替西帕肽。这种最初用于治疗2型糖尿病的药物在帮助人们减肥方面显示出了非凡的效果。事实上,它的效果几乎可以与减肥手术相媲美,并且优于迄今为止临床试验的任何其他药物。然而,目前尚不清楚替西帕肽是如何达到这些显著效果的。这就是我们研究的切入点。我们的目标是深入研究替西帕肽实现其显著临床效果的机制,特别关注其对大脑的影响,因为我们认为这是药物对体重产生主要影响的地方。我们将使用“反向转化”方法,这意味着我们从我们从患者经验和临床试验中已经知道的开始,然后使用实验室小鼠模型进行反向研究,以揭示潜在的生物学过程。我们将使用先进的基因工具,可以被认为是先进的生物控制,来找到与药物相互作用的特定脑细胞,以帮助人们减肥。这些工具让我们有能力随时打开或关闭这些细胞,就像用遥控器开关灯一样。这将帮助我们了解这些细胞在药物起作用的地方究竟在做什么。简而言之,我们正试图找到并研究大脑中与这种药物起作用的“减肥”细胞。这项研究的目的是全面了解替西帕肽是如何与人体系统相互作用从而导致体重减轻的。我们相信,这些知识不仅对更好地使用替泽帕肽本身至关重要,而且对指导新疗法的发展也至关重要。此外,通过精确定位这种药物与特定的“减肥”脑细胞相互作用,我们也可能对控制体重的基本过程以及这些过程如何在肥胖中出错有更深入的了解。这一知识可能为未来更个性化和更有效的治疗方法的发展带来希望。因此,我们的研究有可能提供对肥胖更全面的了解,更重要的是,为开发更有效、可扩展和负担得起的解决方案提供信息,以应对这一广泛的健康挑战。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Giuseppe D'Agostino其他文献
Palmitoylethanolamide modulates pentobarbital-evoked hypnotic effect in mice: <strong>Involvement of allopregnanolone biosynthesis</strong>
- DOI:
10.1016/j.euroneuro.2009.09.003 - 发表时间:
2010-03-01 - 期刊:
- 影响因子:
- 作者:
Oscar Sasso;Giovanna La Rana;Sergio Vitiello;Roberto Russo;Giuseppe D'Agostino;Anna Iacono;Emilio Russo;Rita Citraro;Salvatore Cuzzocrea;Pier Vincenzo Piazza;Giovanbattista De Sarro;Rosaria Meli;Antonio Calignano - 通讯作者:
Antonio Calignano
3138 – REMODELLING OF THE VASCULAR NICHE BY VENETOCLAX AND AZACYTIDINE PROVIDES SELECTIVE ADVANTAGE FOR RESISTANT SUBCLONES IN ACUTE MYELOID LEUKAEMIA
- DOI:
10.1016/j.exphem.2024.104459 - 发表时间:
2024-08-01 - 期刊:
- 影响因子:
- 作者:
Steven Ngo;Dominique Bonnet;Giuseppe D'Agostino;Despoina Papazoglou;Alexander Rochwarger;Christian Schuerch - 通讯作者:
Christian Schuerch
603: SBRT and artificial intelligence in oligometastatic GYN-cancers: a real-world study.
603:寡聚性妇科医生中的SBRT和人工智能:一项现实世界研究。
- DOI:
10.1016/s0167-8140(24)01177-0 - 发表时间:
2024-05-01 - 期刊:
- 影响因子:5.300
- 作者:
Gabriella Macchia;Savino Cilla;Donato Pezzulla;Maura Campitelli;Concetta Laliscia;Roberta Lazzari;Lorena Draghini;Andrei Fodor;Giuseppe D'Agostino;Donatella Russo;Vittoria Balcet;Martina Ferioli;Lisa Vicenzi;Arcangela Raguso;Vanessa Di Cataldo;Valeria Epifani;Simona Borghesi;Aida Di Stefano;Edy Ippolito;Vitaliana De Sanctis;Francesco Deodato - 通讯作者:
Francesco Deodato
P2.05-008 Can Stereotactic Body Radiation Therapy (SBRT) Be an Effective Treatment for Lung Metastases From “Radioresistant” Histologies?: Topic: Clinical Outcome
- DOI:
10.1016/j.jtho.2016.11.1442 - 发表时间:
2017-01-01 - 期刊:
- 影响因子:
- 作者:
Davide Franceschini;Fiorenza De Rose;Luca Cozzi;Tiziana Comito;Ciro Franzese;Pierina Navarria;Giuseppe D'Agostino;Marta Scorsetti - 通讯作者:
Marta Scorsetti
Giuseppe D'Agostino的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Giuseppe D'Agostino', 18)}}的其他基金
Immunoregulatory functions of appetite controlling brain circuits
食欲控制脑回路的免疫调节功能
- 批准号:
BB/Y005694/1 - 财政年份:2024
- 资助金额:
$ 84.24万 - 项目类别:
Research Grant
Neuronal circuits that turn off hunger
消除饥饿感的神经回路
- 批准号:
BB/V016318/1 - 财政年份:2022
- 资助金额:
$ 84.24万 - 项目类别:
Research Grant
Neuroimmune regulation of peripheral immune responses by modulation of food intake and energy balance
通过调节食物摄入和能量平衡来调节外周免疫反应的神经免疫
- 批准号:
MR/W004623/1 - 财政年份:2021
- 资助金额:
$ 84.24万 - 项目类别:
Research Grant
Resolving a novel brain circuit controlling appetite and body weight
解决控制食欲和体重的新型大脑回路
- 批准号:
MR/P009824/2 - 财政年份:2019
- 资助金额:
$ 84.24万 - 项目类别:
Fellowship
Resolving a novel brain circuit controlling appetite and body weight
解决控制食欲和体重的新型大脑回路
- 批准号:
MR/P009824/1 - 财政年份:2017
- 资助金额:
$ 84.24万 - 项目类别:
Fellowship
相似国自然基金
Improving modelling of compact binary evolution.
- 批准号:10903001
- 批准年份:2009
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Strategy for Improving Stroke Treatment Response (SISTER) Trial
改善中风治疗反应策略 (SISTER) 试验
- 批准号:
10595947 - 财政年份:2023
- 资助金额:
$ 84.24万 - 项目类别:
Boost: A pragmatic inpatient rehabilitation strategy for improving musculoskeletal arm recovery after stroke
Boost:一种实用的住院康复策略,可改善中风后手臂肌肉骨骼的恢复
- 批准号:
10325263 - 财政年份:2021
- 资助金额:
$ 84.24万 - 项目类别:
Boost: A pragmatic inpatient rehabilitation strategy for improving musculoskeletal arm recovery after stroke
Boost:一种实用的住院康复策略,可改善中风后手臂肌肉骨骼的恢复
- 批准号:
10490452 - 财政年份:2021
- 资助金额:
$ 84.24万 - 项目类别:
Administrative Supplement for: Improving Access to Chiropractic Care for Low Back Pain in Underserved Primary Care Settings: Development and Evaluation of a Multi-level Implementation Strategy
行政补充:改善服务不足的初级保健机构中腰痛脊椎按摩治疗的可及性:制定和评估多层次实施策略
- 批准号:
10400293 - 财政年份:2019
- 资助金额:
$ 84.24万 - 项目类别:
Improving Sleep as a Strategy to Reduce Suicide Risk Among at-Risk Veterans: A Real World Clinical Trial
改善睡眠作为降低高危退伍军人自杀风险的策略:真实世界的临床试验
- 批准号:
10532670 - 财政年份:2019
- 资助金额:
$ 84.24万 - 项目类别:
Improving Sleep as a Strategy to Reduce Suicide Risk Among at-Risk Veterans: A Real World Clinical Trial
改善睡眠作为降低高危退伍军人自杀风险的策略:真实世界的临床试验
- 批准号:
9397857 - 财政年份:2019
- 资助金额:
$ 84.24万 - 项目类别:
A sequenced-strategy for improving outcomes in patients with knee osteoarthritis pain
改善膝骨关节炎疼痛患者预后的序贯策略
- 批准号:
10352674 - 财政年份:2019
- 资助金额:
$ 84.24万 - 项目类别:
Improving Access to Chiropractic Care for Low Back Pain in Underserved Primary Care Settings: Development and Evaluation of a Multi-level Implementation Strategy
改善服务不足的初级保健环境中腰痛脊椎按摩治疗的可及性:制定和评估多层次实施策略
- 批准号:
10474317 - 财政年份:2019
- 资助金额:
$ 84.24万 - 项目类别:
Improving Access to Chiropractic Care for Low Back Pain in Underserved Primary Care Settings: Development and Evaluation of a Multi-level Implementation Strategy
改善服务不足的初级保健环境中腰痛脊椎按摩治疗的可及性:制定和评估多层次实施策略
- 批准号:
9806317 - 财政年份:2019
- 资助金额:
$ 84.24万 - 项目类别:
A sequenced-strategy for improving outcomes in patients with knee osteoarthritis pain
改善膝骨关节炎疼痛患者预后的序贯策略
- 批准号:
10700013 - 财政年份:2019
- 资助金额:
$ 84.24万 - 项目类别: